
|Articles|April 21, 2003
Biologics foursome squares off for psoriasis market
Four biologics compete for psoriasis market
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide
2
White House Announces Action to Increase Competition, Decrease Cost of Biosimilar Development
3
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
4
FDA Approves Mirikizumab as Once Monthly Injection for Moderately to Severely Active Ulcerative Colitis
5


























































































































































